TOKYO, Oct. 22 -- Ministry of Foreign Affairs of Japan issued the following news release: On October 22, the Multilateral Sanctions Monitoring Team (MSMT) released its second report on the theme of "... Read More
TOKYO, Oct. 22 -- Ministry of Foreign Affairs of Japan issued the following news release: On October 22, commencing at 5:50 p.m. for approximately 30 minutes, Mr. MOTEGI Toshimitsu, Minister of Forei... Read More
TOKYO, Oct. 22 -- Ministry of Foreign Affairs of Japan issued the following news release: On October 22, commencing at 4:10 PM for approximately 20 minutes, the closing session of the first day of th... Read More
U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219121) titled 'Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomeruloscler... Read More
U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219264) titled 'Mental Health CPR for Cancer Survivors' on Oct. 15. Brief Summary: This is a parallel, two... Read More
U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07218952) titled 'Radiation Therapy (RT) for Parkinson's Disease (PD)' on Oct. 17. Brief Summary: The purpos... Read More
U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219108) titled 'Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU' on Oct. 01. Brief Summar... Read More
U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219303) titled 'Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer' on Sept... Read More
U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219433) titled 'Implementing a Mobile Health Application for Women Veterans With Urinary Incontinence (MyHe... Read More
U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07218913) titled 'Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Dam... Read More